| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 6, 2007
Accepted on June 4, 2007
Department of Epidemiology and Biostatistics and Institute of Human Genetics, University of California, San Francisco, San Francisco, CA, 94143-0794, USA; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Epidemiology Program, Cancer Research Center of Hawai'i, University of Hawai'i, Honolulu, HI 96813, USA
* To whom correspondence should be addressed. E-mail: chengi{at}humgen.ucsf.edu.
Context: Both circulating levels and genetic variation of insulin-like growth factors (IGF) have been associated with cancer risk, yet the relationship between the two is not well understood.
Objective: To investigate whether common genetic variation in IGF1, IGFBP1 and IGFBP3 influences circulating levels of IGF-I, IGFBP-1 and IGFBP-3, we conducted a cross-sectional study of African-American, Native Hawaiian, Japanese-American, Latino, and White men and women in the Multiethnic Cohort.
Design: Plasma levels of IGF-I, IGFBP-1 and IGBFP-3 were measured by ELISA in a random sample of 837 Multiethnic Cohort participants. Previously identified tag SNPs for IGF1 (29 tag SNPs) and IGFBP1/IGFBP3 (23 tag SNPs) were genotyped among the 837 participants. Analysis of covariance was conducted to test for differences in mean IGF-I, IGFBP-1 and IGFBP-3 levels across respective IGF1, IGFBP1 and IGFBP3 genotypes, adjusting for previously identified dietary and lifestyle correlates.
Results: Five highly correlated IGFBP3 SNPs (rs3110697, rs2854747, rs2854746, rs2854744 and rs2132570) demonstrated strongly significant associations with IGFBP-3 levels when conservatively adjusted for multiple hypothesis testing (Bonferroni adjusted P trends = 7.75 x 10-8 to 1.44 x 10-5). Patterns of associations were consistent across the five racial/ethnic groups.
Conclusion: In summary, our study suggests that common genetic variation in IGFBP3 influences circulating levels of IGFBP-3 among African-Americans, Native Hawaiians, Japanese-Americans, Latinos, and Whites.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |